Advances in erlotinib delivery systems: Addressing challenges and exploring opportunities in EGFR-targeted cancer therapies
Article in Inorganic Chemistry Communications (March 2024)
The most recent citing publications are shown below. View all 102 publications that cite this research output on Dimensions.
The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model
Article in Cell & Bioscience (November 2023)
Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer
Article in Journal of Obstetrics and Gynaecology Research (August 2023)